A review of the neuropharmacological properties of khat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 5, 2008, Pages 1147-1166

  Feyissa, Anteneh M ^a   Kelly, John P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cathinone; Dopamine; Khat; Neuropharmacology; Psychosis

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALCOHOL; ALKALOID; AMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID; CATHA EDULIS EXTRACT; CATHEDULIN; CATHINONE; CLOZAPINE; COCAINE; DIETHYLDITHIOCARBAMIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; IBUPROFEN; METIROSINE; MORPHINE; NALOXONE; NEUROLEPTIC AGENT; NISOXETINE; NOREPHEDRINE; NORPSEUDOEPHEDRINE; PHENOTHIAZINE DERIVATIVE; PHENYLALKYLAMINE; PLANT EXTRACT; PSYCHOSTIMULANT AGENT; TRITIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADDICTION; AFRICA; AGGRESSION; ALCOHOL CONSUMPTION; ALGORITHM; ANALGESIA; ANIMAL BEHAVIOR; ANOREXIA; ASIA; BARK; BRAIN CORTEX; BRAIN SYNAPTOSOME; CAPGRAS SYNDROME; CATHA EDULIS; CHEMICAL ANALYSIS; DEPRESSION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DOPAMINE RELEASE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG CROSS TOLERANCE; DRUG DEPENDENCE; DRUG DETERMINATION; DRUG DISCRIMINATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INTOXICATION; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; DRUG URINE LEVEL; DRUG USE; DRUG WITHDRAWAL; FEEDING BEHAVIOR; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HALLUCINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMICIDE; HOT PLATE TEST; HUMAN; IMMIGRANT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LEGAL ASPECT; LOW DRUG DOSE; MANIC PSYCHOSIS; MASS SPECTROMETRY; MASTICATION; MEDICINAL PLANT; MENTAL DISEASE; MOOD DISORDER; MOTOR ACTIVITY; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PAIN; PARANOID PSYCHOSIS; PARKINSON DISEASE; PERSONALITY DISORDER; PLANT LEAF; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOSIS; REVIEW; SEXUAL BEHAVIOR; SLEEP DEPRIVATION; STEREOTYPY; SUICIDE; SWALLOWING; TAIL FLICK TEST; WEIGHT REDUCTION;

ANIMALS; CATHA; CENTRAL NERVOUS SYSTEM; NEUROPHARMACOLOGY; PLANT EXTRACTS; PSYCHOSES, SUBSTANCE-INDUCED; PUBMED;

EID: 49849093906     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.033     Document Type: Review

References (185)

1. Abdulwaheb M., Makonnen E., Debella A., and Abebe D. Effect of Catha edulis foresk (khat) extracts on male rat sexual behavior. J Ethnopharmacol 110 (2007) 250-256
2. Alem A., and Shibre T. Khat induced psychosis and its medico-legal implication: a case report. Ethiop Med J 35 (1997) 137-139
3. Alem A., Kebede D., and Kullgren G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Acta Psychiatr Scand Suppl 397 (1999) 84-91
4. Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin Drug Saf 4 (2005) 1145-1154
5. Al-Hebshi N.N., and Skaug N. Khat (Catha edulis)-an updated review. Addict Biol 10 (2005) 299-307
6. Al-Meshal I.A., Qureshi S., Ageel A.M., and Tariq M. The toxicity of Catha edulis (khat) in mice. J Subst Abuse 3 (1991) 107-115
7. Al-Motarreb A., Baker K., and Broadley K.J. Khat: pharmacological and medical aspects and its social use in Yemen. Phytother Res 16 (2002) 403-413
8. Al-Obaid A.M., al-Tamrah S.A., Aly F.A., and Alwarthan A.A. Determination of (S) (-)-cathinone by spectrophotometric detection. J Pharm Biomed Anal 17 (1998) 321-326
9. Al-Zubairi A., Al-Habori M., and Al-Geiry A. Effect of Catha edulis (khat) chewing on plasma lipid peroxidation. J Ethnopharmacol 87 (2003) 3-9
10. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. fourth edition (1994), American Psychiatric Press, Washington, DC (DSM-IV)
11. Babayan E.A., Barkov N.K., and Machula A.I. Mediator mechanisms of cathinone effects on animal behaviour. Drug Alcohol Depend 12 (1983) 31-35
12. Banjaw M.Y., and Schmidt W.J. Behavioural sensitisation following repeated intermittent oral administration of Catha edulis in rats. Behav Brain Res 156 (2005) 181-189
13. Banjaw M.Y., and Schmidt W.J. Catha edulis extract and its active principle cathinone induce ipsilateral rotation in unilaterally lesioned rats. Behav Pharmacol 17 (2006) 615-620
14. Banjaw M.Y., Mayerhofer A., and Schmidt W.J. Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat. Synapse 49 (2003) 232-238
15. Banjaw M.Y., Fendt M., and Schmidt W.J. Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats. Behav Brain Res 160 (2005) 365-373
16. Banjaw M.Y., Miczek K., and Schmidt W.J. Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats. J Neural Transm 113 (2006) 543-556
17. Baker A., and Dawe S. Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Aust Psychol 40 (2005) 87-94
18. Baron D.N. The qat party. BMJ 319 (1999) 500
19. Belew M., Kebede D., Kassaye M., and Enquoselassie F. The magnitude of khat use and its association with health, nutrition and socio-economic status. Ethiop Med J 38 (2000) 11-26
20. Berardelli A., Capocaccia L., Pacitti C., Tancredi V., Quinteri F., and Elmi A.S. Behavioural and EEG effects induced by an amphetamine like substance (cathinone) in rats. Pharmacol Res Commun 12 (1980) 959-964
21. Bentur Y., Bloom-Krasik A., and Raikhlin-Eisenkraft B. Illicit cathinone ("Hagigat") poisoning. Clin Toxicol 15 (2007) 1-5
22. Beyer J., Peters F.T., Kraemer T., and Maurer H.H. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. J Mass Spectrom 42 (2007) 150-156
23. Bhui K., Abdi A., Abdi M., Pereira S., Dualeh M., Robertson D., et al. Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees. Soc Psychiatry Psychiatr Epidemiol 38 (2003) 35-43
24. Bhui K., Craig T., Mohamud S., Warfa N., Stansfeld S.A., Thornicroft G., et al. Mental disorders among Somali refugees: developing culturally appropriate measures and assessing socio-cultural risk factors. Soc Psychiatry Psychiatr Epidemiol 41 (2006) 400-408
25. Bimerew M.S., Sonn F.C., and Kortenbout W.P. Substance abuse and the risk of readmission of people with schizophrenia at Amanuel Psychiatric Hospital, Ethiopia. Curationis 30 (2007) 74-81
26. Brenneisen R., and Geisshüsler S. Phenylpentenylamines from Catha edulis. J Nat Prod 50 (1987) 1188-1189
27. Brenneisen R., Fisch H.U., Koelbing U., Geisshüsler S., and Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br J Clin Pharmacol 30 (1990) 825-828
28. Bronson M.E., Jiang W., DeRuiter J., and Clark C.R. A behavioral comparison of Nexus, cathinone, BDB, and MDA. Pharmacol Biochem Behav 51 (1995) 473-475
29. Browne D.L. Qat use in New York City. NIDA Res Monogr 105 (1990) 464-465
30. Calcagnetti D.J., and Schechter M.D. Increases in the locomotor activity of rats after intracerebral administration of cathinone. Brain Res Bull 29 (1992) 843-846
31. Calcagnetti D.J., and Schechter M.D. Psychostimulant-induced activity is attenuated by two putative dopamine release inhibitors. Pharmacol Biochem Behav 43 (1992) 1023-1031
32. Calcagnetti D.J., and Schechter M.D. Place preference for the psychostimulant cathinone is blocked by pretreatment with a dopamine release inhibitor. Prog Neuropsychopharmacol Biol Psychiatry 17 (1993) 637-649
33. Cleary L., and Docherty J.R. Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. Eur J Pharmacol 476 (2003) 31-34
34. Connor J., Makonnen E., and Rostom A. Comparison of analgesic effects of khat (Catha edulis Forsk.) extract, D-amphetamine and ibuprofen in mice. J Pharm Pharmacol 52 (2000) 107-110
35. Connor J.D., Rostom A., and Makonnen E. Comparison of effects of khat extract and amphetamine on motor behaviors in mice. J Ethnopharmacol 81 (2002) 65-71
36. Cox G., and Rampes R. Adverse effects of khat: a review. Adv Psychiatr Treat 9 (2003) 456-463
37. Critchlow S., and Seifert R. Khat-induced paranoid psychosis. Br J Psychiatry 150 (1987) 247-249
38. Crombie L. The cathedulin alkaloids. Bull Narc 32 (1980) 37-50
39. Cunningham T. Culture of khat. Nurs Stand 13 (1998) 25
40. Della Bella D., Carenzi A., Frigeni V., Reggiani A., and Zambon A. Involvement of monoaminergic and peptidergic components in cathinone-induced analgesia. Eur J Pharmacol 114 (1985) 231-234
41. Dimba E.A., Gjertsen B.T., Bredholt T., Fossan K.O., Costea D.E., Francis G.W., et al. Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and-8 in human leukaemia cells. Br J Cancer 91 (2004) 1726-1734
42. Drake P.H. Khat-chewing in the Near East. Lancet 8584 (1988) 532-533
43. Eisenberg M.S., Maher T.J., and Silverman H.I. A comparison of the effects of phenylpropanolamine, d-amphetamine and d-norpseudoephedrine on open-field locomotion and food intake in the rat. Appetite 9 (1987) 31-37
44. El-Haj B.M., Al-Amri A.M., Hassan M.H., Ali H.S., and Bin Khadem R.K. The use of cyclohexanone as a "derivatizing" reagent for the GC-MS detection of amphetamines and ephedrines in seizures and the urine. Forensic Sci Int 135 (2003) 16-26
45. Ellison G. Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry. Eur Neuropsychopharmacol 12 (2002) 287-297
46. Elmi A.S. The chewing of khat in Somalia. J Ethnopharmacol 8 (1983) 163-176
47. Elmi A.S., Ahmed Y.H., and Samatar M.S. Experience in the control of khat-chewing in Somalia. Bull Narc 39 (1987) 51-57
48. Fasanmade A., Kwok E., and Newman L. Oral squamous cell carcinoma associated with khat chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 53-55
49. Fleckenstein A.E., Haughey H.M., Metzger R.R., Kokoshka J.M., Riddle E.L., Hanson J.E., et al. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382 (1999) 45-49
50. Foltin R.W., and Schuster C.R. Behavioral tolerance and cross-tolerance to dl cathinone and d-amphetamine in rats. J Pharmacol Exp Ther 222 (1982) 126-131
51. Foltin R.W., and Schuster C.R. Interaction between the effects of intragastric meals and drugs on feeding in rhesus monkeys. J Pharmacol Exp Ther 226 (1983) 405-410
52. Foltin R.W., Woolverton W.L., and Schuster C.R. Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration. J Pharmacol Exp Ther 226 (1983) 411-418
53. Geisshüsler S., and Brenneisen R. The content of psychoactive phenylpropyl and phenylpentenyl khatamines in Catha edulis Forsk. of different origin. J Ethnopharmacol 19 (1987) 269-277
54. Giannini A.J., and Castellani S. A manic-like psychosis due to khat (Catha edulis Forsk.). J Toxicol Clin Toxicol 19 (1982) 455-459
55. Giannini A.J., Miller N.S., and Turner C.E. Treatment of khat addiction. J Subst Abuse Treat 9 (1992) 379-382
56. Glennon R.A., and Liebowitz S.M. Serotonin receptor affinity of cathinone and related analogues. J Med Chem 25 (1982) 393-397
57. Glennon R.A., Schechter M.D., and Rosecrans J.A. Discriminative stimulus properties of S(-)-and R(+)-cathinone, (+)-cathine and several structural modifications. Pharmacol Biochem Behav 21 (1984) 1-3
58. Gordon T.L., Meehan S.M., and Schechter M.D. Differential effects of nicotine but not cathinone on motor activity of P and NP rats. Pharmacol Biochem Behav 44 (1993) 657-659
59. Gosnell B.A., Yracheta J.M., Bell S.M., and Lane K.E. Intravenous self administration of cathinone by rats. Behav Pharmacol 7 (1996) 526-531
60. Goudie A.J. Comparative effects of cathinone and amphetamine on fixed-interval operant responding: a rate-dependency analysis. Pharmacol Biochem Behav 23 (1985) 355-365
61. Goudie A.J. Importing khat, legal but dangerous. Lancet 8571 (1987) 1340-1341
62. Goudie A.J. Discriminative stimulus properties of amphetamine, cathinone, and related agents. NIDA Res Monogr 116 (1991) 45-60
63. Goudie A.J., and Newton T. The puzzle of drug-induced conditioned taste aversion: comparative studies with cathinone and amphetamine. Psychopharmacology 87 (1985) 328-333
64. Goudie A.J., Atkinson J., and West C.R. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. Neuropharmacology 25 (1986) 85-94
65. Gough S.P., and Cookson I.P. Khat-induced schizophreniform psychosis in UK. Lancet 8374 (1984) 455
66. Granek M., Shalev A., and Weingarten A.M. Khat-induced hypnagogic hallucinations. Acta Psychiatr Scand 78 (1988) 458-461
67. Griffiths P., Gossop M., Wickenden S., Dunworth J., Harris K., and Lloyd C. A transcultural pattern of drug use: qat (khat) in the UK. Br J Psychiatry 170 (1997) 281-284
68. Guantai A.N., and Maitai C.K. Metabolism of cathinone to d norpseudoephedrine in humans. J Pharm Sci 72 (1983) 1217-1218
69. Gugelmann R., von Allmen M., Brenneisen R., and Porzig H. Quantitative differences in the pharmacological effects of (+)- and (-)-cathinone. Experientia 41 (1985) 1568-1571
70. Halbach H. Medical aspects of the chewing of khat leaves. Bull World Health Organ 47 (1972) 21-29
71. Halbach H. Khat-the problem today. NIDA Res Monogr 27 (1979) 318-319
72. Halket J.M., Karasu Z., and Murray-Lyon I.M. Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.). J Ethnopharmacol 49 (1995) 111-113
73. Hassan N.A., Gunaid A.A., El Khally F.M., and Murray-Lyon I.M. The subjective effects of chewing qat leaves in human volunteers. Saudi Med J 23 (2002) 850-853
74. Hassan N.A., Gunaid A.A., and Murray-Lyon I.M. Khat (Catha edulis): health aspects of khat chewing. East Mediterr Health J 13 (2007) 706-718
75. Hattab F.N., and Angmar-Månsson B. Fluoride content in khat (Catha edulis) chewing leaves. Arch Oral Biol 45 (2000) 253-255
76. Huang D., and Wilson M.C. Comparative discriminative stimulus properties of dl-cathinone, d-amphetamine, and cocaine in rats. Pharmacol Biochem Behav 24 (1986) 205-210
77. Ihunwo A.O., Kayanja F.I., and Amadi-Ihunwo U.B. Use and perception of the psychostimulant, khat (Catha edulis) among three occupational groups in south western Uganda. East Afr Med J 81 (2004) 468-473
78. Islam M.W., Tariq M., Ageel A.M., el-Feraly F.S., al-Meshal I.A., and Ashraf I. An evaluation of the male reproductive toxicity of cathinone. Toxicology 60 (1990) 223-234
79. Jansson T., Kristiansson B., and Qirbi A. Effect of khat on uteroplacental blood flow in awake, chronically catheterized, late-pregnant guinea pigs. J Ethnopharmacol 23 (1988) 19-26
80. Johanson C.E., and Schuster C.R. A comparison of the behavioral effects of l- and dl-cathinone and d-amphetamine. J Pharmacol Exp Ther 219 (1981) 355-362
81. Kalix P. A constituent of khat leaves with amphetamine-like releasing properties. Eur J Pharmacol 68 (1980) 213-215
82. Kalix P. Hypermotility of the amphetamine type induced by a constituent of khat leaves. Br J Pharmacol 68 (1980) 11-13
83. Kalix P. Cathinone, an alkaloid from khat leaves with an amphetamine-like releasing effect. Psychopharmacology 74 (1981) 269-270
84. Kalix P. The amphetamine-like releasing effect of the alkaloid (-)cathinone on rat nucleus accumbens and rabbit caudate nucleus. Prog Neuropsychopharmacol Biol Psychiatry 6 (1982) 43-49
85. Kalix P. A comparison of the catecholamine releasing effect of the khat alkaloids (-)-cathinone and (+)-norpseudoephedrine. Drug Alcohol Depend 11 (1983) 395-401
86. Kalix P. Effect of the alkaloid (-)-cathinone on the release of radioactivity from rat striatal tissue prelabelled with 3H-serotonin. Neuropsychobiology 12 (1984) 127-129
87. Kalix P. Pharmacological properties of the stimulant khat. Pharmacol Ther 48 (1990) 397-416
88. Kalix P., and Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol Rev 37 (1985) 149-164
89. Kalix P., and Glennon R.A. Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochem Pharmacol 35 (1986) 3015-3019
90. Kalix P., and Khan I. Khat: an amphetamine-like plant material. Bull World Health Organ 62 (1984) 681-686
91. Kalix P., Geisshusler S., Brenneisen R., Koelbing U., and Fisch H.U. Cathinone, a phenylpropylamine alkaolid from khat leaves that has amphetamine effects in humans. NIDA Res Monogr 105 (1990) 289-290
92. Kandela P. Women's rights, a tourist boom, and the power of khat in Yemen. Lancet 9213 (2000) 1437
93. Kebede D., Alem A., Mitike G., Enquselassie F., Berhane F., Abebe Y., et al. Khat and alcohol use and risky sex behaviour among in-school and out-of-school youth in Ethiopia. BMC Public Health 5 (2005) 109
94. Kennedy J.G., Teague J., Rokaw W., and Cooney E. A medical evaluation of the use of qat in North Yemen. Soc Sci Med 17 (1983) 783-793
95. Kervingant D. The consumption of khat in French Somaliland. Bull Narc 32 (1959) 42
96. Kim J.Y., Jung K.S., Kim M.K., Lee J.I., and In M.K. Simultaneous determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 21 (2007) 1705-1720
97. Kite G.C., Ismail M., Simmonds M.S., and Houghton P.J. Use of doubly protonated molecules in the analysis of cathedulins in crude extracts of khat (Catha edulis) by liquid chromatography/serial mass spectrometry. Rapid Commun Mass Spectrom 17 (2003) 1553-1564
98. Knoll J. Studies on the central effects of (-) Cathinone. NIDA Res Monogr 27 (1979) 322-323
99. Krikorian A.D. Khat and its use: an historical perspective. J Ethnopharmacol 12 (1984) 115-178
100. Kristiansson B., Abdul Ghani N., Eriksson M., Garle M., and Qirbi A. Use of khat in lactating women: a pilot study on breast-milk secretion. J Ethnopharmacol 21 (1987) 85-90
101. Li S.M., Campbell B.L., and Katz J.L. Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol Exp Ther 317 (2006) 1088-1096
102. Luqman W., and Danowski T.S. The use of khat (Catha edulis) in Yemen. Social and medical observations. Ann Intern Med 85 (1976) 246-249
103. Lurie I.S., Klein R.F., Dal Cason T.A., LeBelle M.J., Brenneisen R., and Weinberger R.E. Chiral resolution of cationic drugs of forensic interest by capillary electrophoresis with mixtures of neutral and anionic cyclodextrins. Anal Chem 66 (1994) 4019-4026
104. Maitai C.K., and Dhadphale M. Khat-induced paranoid psychosis. Br J Psychiatry 152 (1988) 294
105. Mathys K., and Brenneisen R. Determination of (S)-(-)-cathinone and its metabolites (R,S)-(-)-norephedrine and (R,R)-(-)-norpseudoephedrine in urine by high-performance liquid chromatography with photodiode-array detection. J Chromatogr 593 (1992) 79-85
106. Matloob M.H. Determination of cadmium, lead, copper and zinc in Yemeni khat by anodic stripping voltammetry. East Mediterr Health J 9 (2003) 28-36
107. McKee C.M. Medical and social aspects of qat in Yemen: a review. J R Soc Med 80 (1987) 762-765
108. McLaren P. Khat psychosis. Br J Psychiatry 150 (1987) 712
109. Mereu G.P., Pacitti C., and Argiolas A. Effect of (-)-cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain. Life Sci 32 (1983) 1383-1389
110. Morrish P.K., Nicolaou N., Brakkenberg P., and Smith P.E. Leukoencephalopathy associated with khat misuse. J Neurol Neurosurg Psychiatry 67 (1999) 556
111. Nakahara Y., and Kikura R. Hair analysis for drugs of abuse. XIII. Effect of structural factors on incorporation of drugs into hair: the incorporation rates of amphetamine analogs. Arch Toxicol 70 (1996) 841-849
112. Nencini P. The role of opiate mechanisms in the development of tolerance to the anorectic effects of amphetamines. Pharmacol Biochem Behav 30 (1988) 755-764
113. Nencini P., and Ahmed A.M. Naloxone-reversible antinociceptive activity of cathinone, the active principle of khat, in the mouse and rat. Pharmacol Res Commun 14 (1982) 759-770
114. Nencini P., and Ahmed A.M. Khat consumption: a pharmacological review. Drug Alcohol Depend 23 (1989) 19-29
115. Nencini P., Ahmed A.M., Amiconi G., and Elmi A.S. Tolerance develops to sympathetic effects of khat in humans. Pharmacology 28 (1984) 150-154
116. Nencini P., Amiconi G., Befani O., Abdullahi M.A., and Anania M.C. Possible involvement of amine oxidase inhibition in the sympathetic activation induced by khat (Catha edulis) chewing in humans. J Ethnopharmacol 11 (1984) 79-86
117. Nencini P., Ahmed A.M., and Elmi A.S. Subjective effects of khat chewing in humans. Drug Alcohol Depend 18 (1986) 97-105
118. Nencini P., Johanson C.E., and Schuster C.R. Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effects of cathinone. J Pharmacol Exp Ther 245 (1988) 147-154
119. Nencini P., Grassi M.C., Botan A.A., Asseyr A.F., and Paroli E. Khat chewing spread to the Somali community in Rome. Drug Alcohol Depend 23 (1989) 255-258
120. Nencini P., Fraioli S., Pascucci T., and Nucerito C.V. (-) Norpseudoephedrine, a metabolite of cathinone with amphetamine-like stimulus properties, enhances the analgesic and rate decreasing effects of morphine, but inhibits its discriminative properties. Behav Brain Res 92 (1998) 11-20
121. Nielsen J.A. Cathinone affects dopamine and 5-hydroxytryptamine neurons in vivo as measured by changes in metabolites and synthesis in four forebrain regions in the rat. Neuropharmacology 24 (1985) 845-852
122. Nielsen J.A., and Schechter M.D. Behavioral and neurochemical effects of (-)- and (+/-)-cathinone: dose-response and time-course. Prog Neuropsychopharmacol Biol Psychiatry 9 (1985) 739-743
123. Nielen R.J., van der Heijden F.M., Tuinier S., and Verhoeven W.M. Khat and mushrooms associated with psychosis. World J Biol Psychiatry 5 (2004) 49-53
124. Nordal A. Khat: pharmacognostical aspects. Bull Narc 32 (1980) 51-64
125. Numan N. Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99 (2004) 61-65
126. Odenwald M. Chronic khat use and psychotic disorders: a review of the literature and future prospects. Sucht 53 (2007) 9-22
127. Odenwald M., Neuner F., Schauer M., Elbert T., Catani C., Lingenfelder B., et al. Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Med 12 (2005) 3-5
128. Odenwald M., Lingenfelder B., Schauer M., Neuner F., Rockstroh B., Hinkel H., et al. Screening for posttraumatic stress disorder among somali ex-combatants: a validation study. Confl Health 1 (2007) 10
129. Omolo O.E., and Dhadphale M. Alcohol use among khat (Catha) chewers in Kenya. Br J Addict 82 (1987) 97-99
130. Osorio-Olivares M., Rezende M.C., Sepúlveda-Boza S., Cassels B.K., and Fierro A. MAO inhibition by arylisopropylamines: the effect of oxygen substituents at the beta-position. Bioorg Med Chem 12 (2004) 4055-4066
131. Pantelis C., Hindler C.G., and Taylor J.C. Use and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med 19 (1989) 657-668
132. Patel N.B. Mechanism of action of cathinone: the active ingredient of khat (Catha edulis). East Afr Med J 77 (2000) 329-332
133. Pehek E.A., and Schechter M.D. Discriminative stimulus properties of (+)cathine, an alkaloid of the khat plant. Pharmacol Biochem Behav 36 (1990) 267-271
134. Pehek E.A., Schechter M.D., and Yamamoto B.K. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 29 (1990) 1171-1176
135. Peterson D.W., Maitai C.K., and Sparber S.B. Relative potencies of two phenylalkylamines found in the abused plant Catha edulis, khat. Life Sci 27 (1980) 2143-2147
136. Rosecrans J.A., Campbell O.L., Dewey W.L., and Harris L.S. Discriminative stimulus and neurochemical mechanisms of cathinone: a preliminary study. NIDA Res Monogr 27 (1979) 328-329
137. Rothman R.B., Vu N., Partilla J.S., Roth B.L., Hufeisen S.J., Compton-Toth B.A., et al. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307 (2003) 138-145
138. Rousseau C., Said T.M., Gagné M.J., and Bibeau G. Between myth and madness: the premigration dream of leaving among young Somali refugees. Cult Med Psychiatry 22 (1998) 385-411
139. Saha S., and Dollery C. Severe ischaemic cardiomyopathy associated with khat chewing. J R Soc Med 99 (2006) 316-318
140. Saleh M., Mekkawy H., and el-Komy F. Acute effects of a khat extract on the rat electroencephalogram. J Ethnopharmacol 23 (1988) 291-298
141. Sawair F.A., Al-Mutwakel A., Al-Eryani K., Al-Surhy A., Maruyama S., Cheng J., et al. High relative frequency of oral squamous cell carcinoma in Yemen: qat and tobacco chewing as its aetiological background. Int J Environ Health Res 17 (2007) 185-195
142. Schechter M.D. Induction of and recovery from tolerance to the discriminative stimulus properties of l-cathinone. Pharmacol Biochem Behav 25 (1986) 13-16
143. Schechter M.D. Dopaminergic mediation of a behavioral effect of l-cathinone. Pharmacol Biochem Behav 25 (1986) 337-340
144. Schechter M.D. Temporal parameters of cathinone, amphetamine and cocaine. Pharmacol Biochem Behav 34 (1989) 289-292
145. Schechter M.D. Rats become acutely tolerant to cathine after amphetamine or cathinone administration. Psychopharmacology 101 (1990) 126-131
146. Schechter M.D. Dopaminergic nature of acute cathine tolerance. Pharmacol Biochem Behav 36 (1990) 817-820
147. Schechter M.D. Effect of learned behavior upon conditioned place preference to cathinone. Pharmacol Biochem Behav 38 (1991) 7-11
148. Schechter M.D., and Glennon R.A. Cathinone, cocaine and methamphetamine: similarity of behavioral effects. Pharmacol Biochem Behav 22 (1985) 913-916
149. Schechter M.D., and McBurney D. Effect of repeated administrations upon cathinone discrimination and conditioned place preference. Gen Pharmacol 22 (1991) 779-782
150. Schechter M.D., and Meehan S.M. Conditioned place preference produced by the psychostimulant cathinone. Eur J Pharmacol 232 (1993) 135-138
151. Schechter M.D., Rosecrans J.A., and Glennon R.A. Comparison of behavioral effects of cathinone, amphetamine and apomorphine. Pharmacol Biochem Behav 20 (1984) 181-184
152. Schechter M.D., Schechter J.B., and Calcagnetti D.J. Direct microinjection of cathinone into the rat brain produces discriminative stimuli. Pharmacol Biochem Behav 42 (1992) 619-623
153. Schuster C.R., and Johanson C.E. Behavioral studies of cathinone in monkeys and rats. NIDA Res Monogr 27 (1979) 324-325
154. Schramm-Sapyta N.L. Drug addiction: what can animal models teach us?. Preclinica 2 (2004) 417-421
155. Selassie S.G., and Gebre A. Rapid assessment of drug abuse in Ethiopia. Bull Narc 48 (1996) 53-63
156. Sporkert F., Pragst F., Bachus R., Masuhr F., and Harms L. Determination of cathinone, cathine and norephedrine in hair of Yemenite khat chewers. Forensic Sci Int 133 (2003) 39-46
157. Stevenson M., Fitzgerald J., and Banwell C. Chewing as a social act: cultural displacement and khat consumption in the East African communities of Melbourne. Drug Alcohol Rev 15 (1996) 73-82
158. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75 (2005) 406-433
159. Szendrei K. The chemistry of khat. Bull Narc 32 (1980) 5-35
160. Taha S.A., Ageel A.M., Islam M.W., and Ginawi O.T. Effect of (-)-cathinone, a psychoactive alkaloid from khat (Catha edulis Forsk.) and caffeine on sexual behaviour in rats. Pharmacol Res 31 (1995) 299-303
161. Toennes S.W., and Kauert G.F. Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing. Clin Chem 48 (2002) 1715-1719
162. Toennes S.W., and Kauert G.F. Driving under the influence of khat-alkaloid concentrations and observations in forensic cases. Forensic Sci Int 140 (2004) 85-90
163. Toennes S.W., Harder S., Schramm M., Niess C., and Kauert G.F. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol 56 (2003) 125-130
164. Vanwalleghem I.E., Vanwalleghem P.W., and De Bleecker J.L. Khat chewing can cause stroke. Cerebrovasc Dis 22 (2006) 198-200
165. Vislobokov A.I., Mantsev V.V., and Kuzmin A.V. Cocaine, amphetamine and cathinone, but not nomifensine and pargyline increase calcium inward current in internally perfused neurons. Life Sci 52 (1993) 261-265
166. Wagner G.C., Preston K., Ricaurte G.A., Schuster C.R., and Seiden L.S. Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug Alcohol Depend 9 (1982) 279-284
167. Walter H.P. Drink-drive: broken jaw, lager and khat ingestion. J Clin Forensic Med 3 (1996) 51-53
168. Warfa N., Klein A., Bhui K., Leavey G., Craig T., and Alfred S.S. Khat use and mental illness: a critical review. Soc Sci Med 65 (2007) 309-318
169. Weir S., and Thuriaux M.C. Importing khat. Lancet 8582 (1988) 414
170. White J.D. The chemistry of khat. An approach to the synthesis of euonyminol. Pure Appl Chem 66 (1994) 2183-2188
171. WHO. Review of the pharmacology of khat. Report of a WHO advisory group. Bull Narc 32 (1980) 83-93
172. WHO. WHO Expert Committee on Drug Dependence. World Health Organ Tech Rep Ser 915 (2003) 1-26
173. WHO. WHO Expert Committee on Drug Dependence. World Health Organ Tech Rep Ser 942 (2006) 1-21
174. Widler P., Mathys K., Brenneisen R., Kalix P., and Fisch H.U. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin Pharmacol Ther 55 (1994) 556-562
175. Willner P. Animal models of addiction. Hum Psychopharmacol Clin Exp 12 S2 (1997) 59-68
176. Wolgin D.L., and Munoz J.R. Role of instrumental learning in tolerance to cathinone hypophagia. Behav Neurosci 120 (2006) 362-370
177. Woolverton W.L. A review of the effects of repeated administration of selected phenylethylamines. Drug Alcohol Depend 17 (1986) 143-150
178. Woolverton W.L., and Johanson C.E. Preference in rhesus monkeys given a choice between cocaine and d,l-cathinone. J Exp Anal Behav 41 (1984) 35-43
179. Yanagita T. Studies on cathinones: cardiovascular and behavioral effects in rats and self-administration experiment in rhesus monkeys. NIDA Res Monogr 27 (1979) 326-327
180. Yanagita T. Intravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane in rhesus monkeys. Drug Alcohol Depend 17 (1986) 135-141
181. Yousef G., Huq Z., and Lambert T. Khat chewing as a cause of psychosis. Br J Hosp Med 54 (1995) 322-326
182. Zein Z.A. Polydrug abuse among Ethiopian university students with particular reference to khat (Catha edulis). J Trop Med Hyg 91 (1988) 71-75
183. Zelger J.L., and Carlini E.A. Anorexigenic effects of two amines obtained from Catha edulis Forsk. (Khat) in rats. Pharmacol Biochem Behav 12 (1980) 701-705
184. Zelger J.L., and Carlini E.A. Influence of cathinone (alpha-aminopropiophenone) and cathine (phenylpropanolamine) on circling behavior and on the uptake and release of [3H] dopamine in striatal slices of rats. Neuropharmacology 20 (1981) 839-843
185. Zelger J.L., Schorno H.X., and Carlini E.A. Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk.: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine. Bull Narc 32 (1980) 67-81